120 related articles for article (PubMed ID: 38631512)
1. EPA and DHA differentially improve insulin resistance by reducing adipose tissue inflammation-targeting GPR120/PPARγ pathway.
Yang X; Li X; Hu M; Huang J; Yu S; Zeng H; Mao L
J Nutr Biochem; 2024 Aug; 130():109648. PubMed ID: 38631512
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA.
Oliver E; McGillicuddy FC; Harford KA; Reynolds CM; Phillips CM; Ferguson JF; Roche HM
J Nutr Biochem; 2012 Sep; 23(9):1192-200. PubMed ID: 22137266
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic and Eicosapentaenoic Acids Promote the Accumulation of Browning-Related Myokines via Calcium Signaling in Insulin-Resistant Mice.
Wei W; Yu S; Zeng H; Tan W; Hu M; Huang J; Li X; Mao L
J Nutr; 2024 Apr; 154(4):1271-1281. PubMed ID: 38367811
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic and Docosahexaenoic Acids Differentially Alter Gut Microbiome and Reverse High-Fat Diet-Induced Insulin Resistance.
Zhuang P; Zhang Y; Shou Q; Li H; Zhu Y; He L; Chen J; Jiao J
Mol Nutr Food Res; 2020 May; 64(10):e1900946. PubMed ID: 32298529
[TBL] [Abstract][Full Text] [Related]
5. Different ratios of DHA/EPA reverses insulin resistance by improving adipocyte dysfunction and lipid disorders in HFD-induced IR mice.
Yu S; Xie Q; Tan W; Hu M; Xu G; Zhang X; Xie G; Mao L
Food Funct; 2023 Jan; 14(2):1179-1197. PubMed ID: 36602027
[No Abstract] [Full Text] [Related]
6. Differential effects of EPA and DHA on PPARγ-mediated sympathetic innervation in infarcted rat hearts by GPR120-dependent and -independent mechanisms.
Wang CP; Lee CC; Wu DY; Chen SY; Lee TM
J Nutr Biochem; 2022 May; 103():108950. PubMed ID: 35121022
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes.
Oster RT; Tishinsky JM; Yuan Z; Robinson LE
Appl Physiol Nutr Metab; 2010 Dec; 35(6):783-9. PubMed ID: 21164549
[TBL] [Abstract][Full Text] [Related]
8. Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice.
Wei W; Hu M; Huang J; Yu S; Li X; Li Y; Mao L
Food Funct; 2021 Feb; 12(4):1614-1625. PubMed ID: 33476356
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid shows anti-inflammatory effect via GPR120 in 3T3-L1 adipocytes and attenuates adipose tissue inflammation in diet-induced obese mice.
Yamada H; Umemoto T; Kakei M; Momomura SI; Kawakami M; Ishikawa SE; Hara K
Nutr Metab (Lond); 2017; 14():33. PubMed ID: 28503189
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic and docosapentaenoic acids lessen the expression of PPARγ/Cidec affecting adipogenesis in cultured 3T3-L1 adipocytes.
Martins FF; Aguila MB; Mandarim-de-Lacerda CA
Acta Histochem; 2020 Feb; 122(2):151504. PubMed ID: 31955908
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes.
Tishinsky JM; Ma DW; Robinson LE
Obesity (Silver Spring); 2011 Feb; 19(2):262-8. PubMed ID: 20814411
[TBL] [Abstract][Full Text] [Related]
12. DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes.
Song J; Li C; Lv Y; Zhang Y; Amakye WK; Mao L
Nutr Metab (Lond); 2017; 14():52. PubMed ID: 28811832
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway.
Nakamoto K; Tokuyama S
Pharmacology; 2022; 107(5-6):330-338. PubMed ID: 35189618
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes.
Hasan AU; Ohmori K; Konishi K; Igarashi J; Hashimoto T; Kamitori K; Yamaguchi F; Tsukamoto I; Uyama T; Ishihara Y; Noma T; Tokuda M; Kohno M
Mol Cell Endocrinol; 2015 May; 406():10-8. PubMed ID: 25697344
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.
Marion-Letellier R; Butler M; Déchelotte P; Playford RJ; Ghosh S
Am J Clin Nutr; 2008 Apr; 87(4):939-48. PubMed ID: 18400717
[TBL] [Abstract][Full Text] [Related]
16. DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ.
Yin H; Liu Y; Yue H; Tian Y; Dong P; Xue C; Zhao YT; Zhao Z; Wang J
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364935
[TBL] [Abstract][Full Text] [Related]
17. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.
Kondreddy VK; Kamatham AN
Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture model.
De Boer AA; Monk JM; Robinson LE
PLoS One; 2014; 9(1):e85037. PubMed ID: 24465472
[TBL] [Abstract][Full Text] [Related]
20. Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice.
Xu P; Wang H; Kayoumu A; Wang M; Huang W; Liu G
Nutr Metab (Lond); 2015; 12():58. PubMed ID: 26690553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
